Dashboard
Manage Tickers

IBRXImmunityBio, Inc.

Nasdaq immunitybio.com


$ 7.92 $ -0.34 (-4.12 %)    

Wednesday, 08-May-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 7.92
$ 8.07
$ 0.00 x 0
$ 0.00 x 0
$ 7.68 - $ 8.12
$ 1.25 - $ 10.53
5,025,439
na
4.03B
$ 1.40
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-19-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-04-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-07-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-25-2020 12-31-2019 10-K
18 11-05-2019 09-30-2019 10-Q
19 08-06-2019 06-30-2019 10-Q
20 05-08-2019 03-31-2019 10-Q
21 03-13-2019 12-31-2018 10-K
22 11-07-2018 09-30-2018 10-Q
23 08-06-2018 06-30-2018 10-Q
24 05-07-2018 03-31-2018 10-Q
25 03-12-2018 12-31-2017 10-K
26 11-07-2017 09-30-2017 10-Q
27 08-07-2017 06-30-2017 10-Q
28 05-08-2017 03-31-2017 10-Q
29 03-15-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 09-10-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

tempur-sealy-posts-upbeat-earnings-joins-fibrogen-coca-cola-consolidated-fabrinet-and-other-big-stocks-moving-higher-on-tuesday
Tempur Sealy Posts Upbeat Earnings, Joins ...
05/07/2024 14:53:56

immunitybio-completes-gmp-drug-substance-manufacturing-sufficient-for-170000-doses-of-anktiva
ImmunityBio Completes GMP Drug Substance M...
05/07/2024 12:18:59

ANKTIVA® Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA pro...

serum-institute-of-india-inks-large-scale-supply-deal-for-bcg-use-in-immunitybios-bladder-cancer-combo-therapy
Serum Institute of India Inks Large-Scale ...
05/03/2024 16:19:55

Unlocking global access to Bacillus Calmette-Guerin (BCG) for cancer therapy. ImmunityBio partners with Serum Institute to expa...

amgen-posts-upbeat-results-joins-onespan-paylocity-holding-mercadolibre-and-other-big-stocks-moving-higher-on-friday
Amgen Posts Upbeat Results, Joins OneSpan,...
05/03/2024 14:15:59

Core News & Articles
Top 10 Trending Stocks On WallStreetBets A...
05/03/2024 13:18:20

AAPLNVDATSLACOINBAPLTRDJTAIIBRXCVNAData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment 

immunitybio-shares-are-trading-higher-after-the-company-announced-it-signed-an-exclusive-global-arrangement-with-the-serum-institute-of-india-the-company-will-be-supplied-with-bacillus-calmette-guerin
ImmunityBio shares are trading higher afte...
05/03/2024 10:53:35

immunitybio-serum-institute-of-india-agree-on-an-exclusive-arrangement-for-global-supply-of-bacillus-calmette-guerin-across-all-cancer-types
ImmunityBio, Serum Institute Of India Agre...
05/02/2024 20:45:46

Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio's recently ap...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/02/2024 17:35:24

check-out-what-whales-are-doing-with-ibrx
Check Out What Whales Are Doing With IBRX
04/30/2024 17:01:22

immunitybio-executive-chairman-dr-patrick-soon-shiong-to-discuss-anktiva-approval-in-fireside-chat-at-annual-conference-of-american-urological-association
ImmunityBio Executive Chairman Dr. Patrick...
04/30/2024 13:05:25

Core News & Articles
Why Clever Leaves Holdings Shares Are Trad...
04/29/2024 17:04:01

tesla-deciphera-pharmaceuticals-heartland-financial-and-other-big-stocks-moving-higher-on-monday
Tesla, Deciphera Pharmaceuticals, Heartlan...
04/29/2024 14:47:40

Core News & Articles
Top 10 Trending Stocks On WallStreetBets A...
04/29/2024 13:14:52

TSLASOFINVDAAAPLFSDIBRXAMDAMZNMETAAIData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment 

piper-sandler-maintains-neutral-on-immunitybio-raises-price-target-to-6
Piper Sandler Maintains Neutral on Immunit...
04/29/2024 11:49:52

Piper Sandler analyst Joseph Catanzaro maintains ImmunityBio (NASDAQ:IBRX) with a Neutral and raises the price target from $...

why-philips-shares-are-trading-higher-by-37-here-are-20-stocks-moving-premarket
Why Philips Shares Are Trading Higher By 3...
04/29/2024 09:53:03

whats-going-on-with-immunitybio-stock
What's Going On With ImmunityBio Stock?
04/26/2024 19:26:42

ImmunityBio said the QUILT 3.055 trial shows median overall survival almost double that of standard of care chemotherapy in 2nd...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
04/26/2024 16:31:22

why-teradyne-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket
Why Teradyne Shares Are Trading Higher By ...
04/25/2024 10:12:22

immunitybio-announces-results-of-anktiva-combined-with-checkpoint-inhibitors-in-non-small-cell-lung-cancer-schedules-meeting-to-discuss-registration-path-for-anktiva-in-lung-cancer-with-fda
Immunitybio Announces Results Of Anktiva C...
04/25/2024 06:57:45

QUILT 3.055 trial completed and shows median overall survival almost double that of standard of care chemotherapy in 2nd- and...

fda-approves-immunitybios-bladder-cancer-drug-stock-rallies
FDA Approves ImmunityBio's Bladder Cancer ...
04/23/2024 13:54:43

FDA approves ImmunityBio's Anktiva plus Bacillus Calmette-Guérin for BCG-unresponsive non-muscle invasive bladder cancer. A...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION